Fundz

Radiomer Therapeutics raises pre-seed funding under Fannin Partners

PRIVATEMay 29, 2024

Round Type

Pre-Seed

HoustonBiotechnologyHealth CareTherapeutics

Investors

Fannin Partners

Description

Radiomer Therapeutics has raised an undisclosed amount of pre-seed funding and has launched under Fannin Partners, a Houston life science leader.

Quick answer

Radiomer Therapeutics raised an undisclosed amount in a Pre-Seed round, dated May 29, 2024. Investors: Fannin Partners. Radiomer Therapeutics is based in Houston, Texas, United States.

How much did Radiomer Therapeutics raise?
Radiomer Therapeutics raised an undisclosed amount in a Pre-Seed round on May 29, 2024.
Who invested in Radiomer Therapeutics?
Fannin Partners is named as investors in this round.
What does Radiomer Therapeutics do?
Radiomer Therapeutics is a novel radiopharmaceutical and radioligand therapy platform that leverages Raptamersᵀᴹ (peptide-oligonucleotide hybrids) as a targeting moiety/vector.
Where is Radiomer Therapeutics based and how big is it?
Radiomer Therapeutics is based in Houston, Texas, United States.
Who are the decision-makers at Radiomer Therapeutics?
Fundz holds 1 contact at Radiomer Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Radiomer Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Phio Pharmaceuticals raised $136K on July 11, 2024.
  • HepaRegeniX GmbH raised $16M (Series C) on July 10, 2024.
  • Arsenal Biosciences raised $325M on July 9, 2024.
  • SciRhom GmbH raised $70M (Series A) on July 9, 2024.
  • Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
  • NGM Bio raised $73M on July 5, 2024.

Who to call at Radiomer Therapeutics, and when

A new round usually means Radiomer Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Radiomer Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Radiomer Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Radiomer Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Radiomer Therapeutics

Location

Houston, Texas, United States

About

Radiomer Therapeutics is a novel radiopharmaceutical and radioligand therapy platform that leverages Raptamersᵀᴹ (peptide-oligonucleotide hybrids) as a targeting moiety/vector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Radiomer Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Radiomer Therapeutics's next move

See what Strategic adds

Radiomer Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.